Vice President of Clinical Operations
Patrick Simms is a seasoned biopharma executive with more than 25 years of experience. In his career, he has contributed to numerous drug development programs and drug approvals in multiple therapeutic areas including TRISENOX® (leukemia), TOBI® Inhale (cystic fibrosis) and AFREEZA® (diabetes mellitus). Previously, Patrick was the Vice President of Clinical Operations at the Multiple Myeloma Research Foundation where he worked with some of the most prolific research oncologists and research centers in the United States.
Patrick brings a wealth of experience in the start-up environment having managed Clinical Operations in the early stage startup setting; Angion Biomedica, and Biodel, Inc., as the Vice President of Clinical Operations and Regulatory Affairs.
Patrick has significant experience overseeing early and late stage clinical programs as well as regulatory affairs and has brought clinical programs from early phase to NDA filing.
Patrick’s experience includes genomics-driven oncology studies, phase 3 global registration studies, and studies in orphan disease populations. He has worked in programs with small molecules and biologics. Patrick studied for his B.A. in Chemistry at Western Connecticut Sate University and initially worked as a chemist with Boehringer Ingelheim, and then transitioned into in Regulatory Affairs with Chemwerth Inc where he was overseeing global regulatory affairs. Over the last 16 years of his career Patrick has been successfully leading clinical research operations.